Disc Medicine Inc’s filing revealed that its Director JOHN QUISEL acquired Company’s shares for reported $1.28 million on Dec 23 ’24. In the deal valued at $64.50 per share,19,820 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Quisel John D sold 12,791 shares, generating $844,314 in total proceeds. Upon selling the shares at $66.01, the Chief Executive Officer now owns 72,065 shares.
Before that, JOHN QUISEL bought 12,791 shares. Disc Medicine Inc shares valued at $830,008 were divested by the Director at a price of $64.89 per share.
Morgan Stanley upgraded its Disc Medicine Inc [IRON] rating to an Overweight from a an Equal-weight in a research note published recently. A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in early November from “an Outperform” to “a Strong buy”. Jefferies began covering IRON with “Buy” recommendation on October 23, 2024. Scotiabank started covering the stock on October 16, 2024. It rated IRON as “a Sector outperform”.
Price Performance Review of IRON
On Tuesday, Disc Medicine Inc [NASDAQ:IRON] saw its stock jump 1.88% to $65.01. Over the last five days, the stock has gained 0.38%. Disc Medicine Inc shares have risen nearly 12.97% since the year began. Nevertheless, the stocks have risen 12.31% over the past one year. While a 52-week high of $77.60 was reached on 03/04/24, a 52-week low of $25.60 was recorded on 04/01/24. SMA at 50 days reached $59.16, while 200 days put it at $47.06.
Levels Of Support And Resistance For IRON Stock
The 24-hour chart illustrates a support level at 63.25, which if violated will result in even more drops to 61.48. On the upside, there is a resistance level at 66.47. A further resistance level may holdings at 67.92. The Relative Strength Index (RSI) on the 14-day chart is 56.16, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.22, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 45.44%. Stochastics %K at 46.80% indicates the stock is a holding.
How much short interest is there in Disc Medicine Inc?
A steep rise in short interest was recorded in Disc Medicine Inc stocks on 2024-11-29, growing by 1752.0 shares to a total of 1.63 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 1.63 million shares. There was a rise of 0.11%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 22, 2024 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $75 price target.
